Publication details
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Patent |
| MU Faculty or unit | |
| Publisher | United States Patent and Trademark Office |
| State | United States of America |
| Patent's number | US11498920 |
| Web | https://worldwide.espacenet.com/patent/search/family/061837684/publication/US11498920B2?q=US11498920B2 |
| Description | Novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds that are useful in the treatment of lymphomas, leukaemias, and solid tumors. |